Versant Venture Capital V, L.p. - Net Worth and Insider Trading
Versant Venture Capital V, L.p. Net Worth
The estimated net worth of Versant Venture Capital V, L.p. is at least $88 Million dollars as of 2024-11-13. Versant Venture Capital V, L.p. is the 10% Owner of CRISPR Therapeutics AG and owns about 1,729,151 shares of CRISPR Therapeutics AG (CRSP) stock worth over $88 Million. Details can be seen in Versant Venture Capital V, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Versant Venture Capital V, L.p. has not made any transactions after 2018-04-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Versant Venture Capital V, L.p.
Versant Venture Capital V, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Versant Venture Capital V, L.p. owns 6 companies in total, including Repare Therapeutics Inc (RPTX) , Aprea Therapeutics Inc (APRE) , and Crinetics Pharmaceuticals Inc (CRNX) among others .
Click here to see the complete history of Versant Venture Capital V, L.p.’s form 4 insider trades.
Insider Ownership Summary of Versant Venture Capital V, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RPTX | Repare Therapeutics Inc | 2020-12-15 | 10 percent owner |
APRE | Aprea Therapeutics Inc | 2020-04-09 | 10 percent owner |
CRNX | Crinetics Pharmaceuticals Inc | 2018-07-17 | 10 percent owner |
2018-09-27 | 10 percent owner | ||
2018-04-24 | 10 percent owner | ||
2023-07-20 | 10 percent owner |
Versant Venture Capital V, L.p. Latest Holdings Summary
Versant Venture Capital V, L.p. currently owns a total of 1 stock. Versant Venture Capital V, L.p. owns 1,729,151 shares of CRISPR Therapeutics AG (CRSP) as of April 24, 2018, with a value of $88 Million.
Latest Holdings of Versant Venture Capital V, L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | 2018-04-24 | 1,729,151 | 50.73 | 87,719,830 |
Holding Weightings of Versant Venture Capital V, L.p.
Versant Venture Capital V, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Versant Venture Capital V, L.p. has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 22,841 shares on April 24, 2018, which brought Versant Venture Capital V, L.p. around $1 Million.
Insider Trading History of Versant Venture Capital V, L.p.
- 1
Versant Venture Capital V, L.p. Trading Performance
Versant Venture Capital V, L.p. Ownership Network
Ownership Network List of Versant Venture Capital V, L.p.
Ownership Network Relation of Versant Venture Capital V, L.p.
Versant Venture Capital V, L.p. Owned Company Details
What does Repare Therapeutics Inc do?
Who are the key executives at Repare Therapeutics Inc?
Versant Venture Capital V, L.p. is the 10 percent owner of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , EVP & Chief Science Officer Michael Zinda , and EVP & Chief Financial Officer Steve Forte .
Repare Therapeutics Inc (RPTX) Insider Trades Summary
Over the past 18 months, Versant Venture Capital V, L.p. made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .
In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.
Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repare Therapeutics Inc Insider Transactions
Versant Venture Capital V, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Versant Venture Capital V, L.p.. You might contact Versant Venture Capital V, L.p. via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.